Zydus Lifesciences Gets USFDA Orphan Drug Status for Promising Beta-Thalassemia Treatment Business Zydus Lifesciences wins USFDA Orphan Drug tag for Desidustat in beta-thalassemia treatment.
Fatty Liver Affects 1 in 3 Adults Globally: 9 Essential Facts to Protect Your Liver Health Health & Beauty
Driver Falls Asleep, Car Plunges 50 Feet Off Ghaziabad Flyover—Father Dead, Son Survives Miracle Escape Crime
SIR Drive in Bareilly Rekindles Family Bonds as Estranged Children Reach Out for Voter Details National